CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review
Pharmacology & Pharmacy · 2022 · 13 (11) · 483-515
DOI: 10.4236/pp.2022.1311036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology & Pharmacy, 2022. Verfasst von Shammi Binte Bashar und 5 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bashar, S. B., Akhter, Z., Saha, B. C., Himaloy, M. M. I., Kulsum, U., & Rahman, M. R. (2022). CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review. Pharmacology & Pharmacy, 13(11), 483-515. https://doi.org/10.4236/pp.2022.1311036
Vancouver
Bashar SB, Akhter Z, Saha BC, Himaloy MMI, Kulsum U, Rahman MR. CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review. Pharmacology & Pharmacy. 2022;13(11):483-515. doi:10.4236/pp.2022.1311036
BibTeX
@article{Bashar2022,
author = {Bashar, Shammi Binte and Akhter, Zannat and Saha, Bidhan Chandro and Himaloy, Md. Mushfiqul Islam and Kulsum, Umme and Rahman, Md. Rashedur},
title = {CAR T Cell Immunotherapy That Revolutionary Breakthrough in Human Oncology Treatment: A Review},
journal = {Pharmacology & Pharmacy},
year = {2022},
volume = {13},
number = {11},
pages = {483--515},
doi = {10.4236/pp.2022.1311036}
}
EUVIMED